SBC Medical Group (NASDAQ:SBC) Releases Earnings Results

Key Points

• SBC Medical Group reported an earnings per share (EPS) of $0.02, missing analysts' estimates of $0.14 by $0.12.
• The company's quarterly revenue was $43.36 million, falling short of the expected $44.71 million.
• SBC Medical Group's stock saw an increase of 8.6%, trading at $4.41 following the earnings release.

SBC Medical Group (NASDAQ:SBC - Get Free Report) released its quarterly earnings results on Wednesday, August 13th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.12), Zacks reports. SBC Medical Group had a return on equity of 20.76% and a net margin of 17.71%.The firm had revenue of $43.36 million for the quarter, compared to analyst estimates of $44.71 million.

SBC Medical Group Trading Down 2.4%

SBC traded down $0.10 during trading on Wednesday, hitting $3.99. The company's stock had a trading volume of 33,804 shares, compared to its average volume of 47,032. The firm has a market capitalization of $413.40 million, a P/E ratio of 12.47 and a beta of 1.27. SBC Medical Group has a twelve month low of $2.62 and a twelve month high of $19.50. The company has a quick ratio of 3.95, a current ratio of 3.98 and a debt-to-equity ratio of 0.03. The stock's fifty day moving average price is $4.60 and its 200-day moving average price is $4.21.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen lowered SBC Medical Group from a "strong-buy" rating to a "buy" rating in a report on Saturday.

Institutional Trading of SBC Medical Group

Several institutional investors and hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC bought a new position in shares of SBC Medical Group in the second quarter worth $455,000. New York State Common Retirement Fund bought a new position in shares of SBC Medical Group in the 2nd quarter worth $104,000. Finally, XTX Topco Ltd purchased a new stake in shares of SBC Medical Group during the 2nd quarter valued at $64,000. 60.82% of the stock is owned by hedge funds and other institutional investors.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.